Uniting Canada's Psychedelic Community
Become a Friend of the PACWhy we exist
To awaken a revolution of wellbeing
Our Mission
To educate about and advocate for access to all psychedelics as a basic human right
Our Vision
People living in harmony with each other and nature
Our Values
Love, Courage, Communication,
Integrity, Impact, Sustainability
"That psychedelics have been time tested for thousands of years, and being revered across cultures and continents, speaks to their deep history of beneficial influence. Modern science is now validating what our ancestors knew: psychedelics are essential for mental and spiritual well being."
- Paul Stamets
"Psychedelic plants, fungi and compounds are tools for learning; they place in our hands the keys to learn how to become better humans."
- Dennis McKenna
Why join the PAC Business Alliance?
The PAC Business Alliance serves the business in Canada’s psychedelic space. Think of it as the psychedelic chamber of commerce. Contribute to the PAC advocacy regarding legalization of medical psychedelics. Participate in business-focused webinars, networking events, roundtables and research incubators. Network and communicate with the PAC nationwide psychedelic community.
Join the Business AllianceEvents & Webinars
If you haven't signed up for a membership with us, now is the time. When you sign up for our membership or to one of our webinars, you are directly supporting our mission to educate about and advocate for psychedelic medicines.
Furthermore, your membership fees help us directly fund our advocacy campaign "Canada Supports" plus you get the benefit of connecting with others within our community and access to our networking events and webinars.
Sign up for our membership and get access to all the events below!
Past
Upcoming
Event
April 28, 2022
at 4 PM PST / 7 PM EST on Zoom
Interactive Networking Event
with our incredible community, made up of people from across Canada who are passionate about psychedelic and plant medicines.
- Meet others from across the country involved in all facets of the psychedelic and plant medicine space.
- Share your personal experiences and create new friendships with like-minded and like-hearted new friends.
- Network with others who may be interested to learn about your professional services or businesses.
To get the MOST from this special event, you'll want to be sure to join us that day from a quiet environment (with your microphone and video on) so that you can interact easily with your hosts and other participants.
Join us live on April 28, 2022 and participate in the conversation!
Past
Upcoming
Webinar
April 7, 2022
at 4 PM PST / 7 PM EST on Zoom
Jeff Sorensen - Breath Work
Join Jeffrey C Sorensen of breathARMY in discussing the valuable role breathwork can play alongside psychedelic therapies and the similarities between these two modalities in how they impact brain function.
Jeff will provide a brief history and description of techniques that can be useful and complementary in psychedelic therapy.
Jeff will also guide us in a relaxing yet revitalizing breathing session.
Past
Upcoming
Webinar
February 16, 2022
at 4 PM PST / 7 PM EST on Zoom
Psychedelic Advances in the Treatment of Alcohol Use Disorder
MEAI (5-Methoxy-2-aminoindane) is a psychoactive molecule, exerting a euphoric alcohol-like experience & a reduced desire to consume alcohol. It shows a high safety profile in preclinical studies and a promising efficacy.
MEAI is believed to break the vicious binge-drinking cycle at the decision point to drink more alcohol, by potentially innervating neural pathways such as 5-HT1A that lead to “sensible behaviour”.
In this informational and education session, Adjunct Professor Mark Haden, VP of Business Development for Clearmind will discuss the history of MEAI and its classification as a psychedelic, the clinical trial pathway required for the molecule MEAI to become a treatment, and some of the preclinical data.
Canada Supports Campaign
The PAC to introduce new regulatory change to Health Canada
Canada overwhelmingly supports access to new regulations with polling numbers showcasing the need for change including, 78% of Canadians polled support or somewhat support a government that legalized psilocybin-assisted psychotherapy to improve the quality of life for terminally ill patients.
The Psychedelic Association of Canada and other experts from across Canada have been meeting with Members of Parliament, senior government officials, representatives from all parties, and national stakeholders over the past 10 months and encountered unanimous support for access to psilocybin therapy with a palliative diagnosis.
With public support at an all-time high, we are focusing on introducing evidence-informed regulations to officials at Health Canada. We come together with a group of key experts including palliative care professionals, therapists, MDs, non-profit supports, industry, medical and legal experts to communicate, petition, and deliver a regulatory framework that will transform the lives of Canadians who deserve access to medicine that can help them overcome their most debilitating mental anxieties.
Work with us, lend your support and help us create a new path for legal psilocybin-assisted therapy in Canada. #canadasupports
#psychedelicassociation
15,000 signatures!
Decriminalize healing plant medicines and fungi in Canada
Our petition's first go is now over! We gathered close to 15,000 signatures and the petition has been read in the House of Commons this fall. Thank you for your support!
Stay tuned for a NEW petition as we won't stop this campaign until our voices have been heard in Ottawa and across Canada.
Thank you to Chris Bennett, Paul Manly, Kirk Tousaw, Rob Laurie, Jovian Francey, Trevor Millar, and others who started this petition process!
Get more information on psychedelics and the community
Curious about psychedelics and their potential for therapeutic and health benefits? Want to get plugged into the movement locally? Visit our Resources centre for books we recommend, films to watch, a global ecosystem map, training programs, and ongoing clinical trials.
Visit our resources centre